Healthcare LLM and Foundation Model Market Size & Share 2026-2035

Healthcare LLM and Foundation Model Market Size

The global healthcare LLM and foundation model market was valued at USD 2.4 billion in 2025. The market is expected to reach USD 3.1 billion in 2026 to USD 27.7 billion in 2035, growing at a CAGR of 27.7% during the forecast period, according to the latest report published by Global Market Insights Inc.

The robust market growth is primarily driven by the increasing adoption of AI-powered clinical documentation solutions, rising demand for patient engagement and virtual care platforms, expanding use of foundation models in drug discovery and genomics research, and growing integration of multimodal AI across healthcare workflows.

Healthcare LLM and foundation model market consists of advanced artificial intelligence models, including large language models (LLMs), vision foundation models, multimodal foundation models, and biological & genomic foundation models, that are designed to analyze, generate, and interpret healthcare data. These solutions support applications such as clinical documentation, patient engagement, medical imaging, clinical decision support, drug discovery, genomics research, medical coding, and healthcare analytics.

The major players in the market are Microsoft, Google, NVIDIA, OpenAI, and Tempus AI. These companies maintain their competitive position through continuous investments in healthcare-specific AI model development, strategic partnerships with healthcare providers and life sciences organizations, expansion of cloud-based AI platforms, integration of multimodal capabilities, and ongoing innovation in clinical documentation, medical imaging, drug discovery, and decision-support applications.

The market increased from USD 1 billion in 2022 to USD 1.8 billion in 2024, registering a historical growth rate of 32.1%. This growth was primarily driven by the increasing adoption of artificial intelligence across healthcare workflows, rising demand for clinical documentation automation, and growing investments in healthcare-specific large language models and foundation models. Additionally, advancements in generative AI technologies, expanding electronic health record (EHR) adoption, and increasing digitalization of healthcare systems have significantly contributed to market expansion.

Furthermore, the growing volume of healthcare data, including clinical notes, medical images, genomic datasets, and real-world evidence, continues to accelerate demand for healthcare LLMs and foundation models. Healthcare providers are increasingly deploying AI-powered solutions for clinical documentation, patient engagement, medical coding, clinical decision support, and workflow optimization to improve operational efficiency and reduce physician burnout. In addition, pharmaceutical and biotechnology companies are leveraging foundation models for drug discovery, biomarker identification, genomics research, and clinical trial optimization. The increasing adoption of multimodal AI models capable of integrating text, imaging, and genomic information, coupled with growing investments from technology companies and healthcare organizations, is further supporting market growth.

Healthcare LLM and Foundation Model Market Trends

Several trends are shaping the healthcare LLM & foundation model industry. The growing adoption of AI-powered clinical documentation solutions is significantly driving the deployment of healthcare-specific large language models across hospitals, physician practices, and healthcare systems. These solutions help automate administrative tasks such as clinical note generation, medical coding, and documentation workflows, enabling healthcare providers to reduce physician burnout, improve productivity, and enhance care delivery efficiency.

• Advancements in multimodal foundation models represent another key trend influencing market evolution. Healthcare organizations are increasingly adopting models capable of integrating clinical text, medical imaging, laboratory results, genomic information, and real-world patient data into a unified analytical framework. These multimodal systems support more comprehensive clinical decision-making, improved diagnostic accuracy, and personalized treatment planning across diverse disease areas.
• Additionally, the emergence of agent-based clinical AI and healthcare-specific foundation models is enabling greater workflow automation across healthcare settings. Advanced AI systems are increasingly being used to support patient engagement, prior authorization, care coordination, clinical decision support, and population health management. As foundation models become more accurate, explainable, and compliant with healthcare regulations, their adoption is expected to expand across hospitals, payers, research institutions, and life sciences organizations.

Healthcare LLM and Foundation Model Market Analysis

Based on model type, the healthcare LLM and foundation model market is segmented into large language models (LLMs), vision foundation models, multimodal foundation models, and biological & genomic foundation models. The large language models (LLMs) segment has asserted its dominance in the market by securing a significant market share of 61.2% in 2025. The segment is growing at a CAGR of 28% during the forecast period.

• The growing adoption of AI-powered clinical documentation and workflow automation solutions is a key factor driving the dominance of the Large Language Models (LLMs) segment. Healthcare providers are increasingly deploying healthcare-specific LLMs such as Google MedLM, Microsoft DAX Copilot, and Abridge AI, to automate clinical note generation, summarize patient encounters, support medical coding, and reduce administrative burden. These capabilities help improve physician productivity while addressing rising concerns related to clinician burnout.
• Continuous advancements in healthcare-focused LLMs are further supporting segment growth. New generations of models are being trained on medical literature, clinical guidelines, and healthcare datasets to enhance medical reasoning, contextual understanding, and clinical accuracy. As a result, healthcare organizations are increasingly utilizing LLMs for clinical documentation, decision support, medical knowledge retrieval, and workflow optimization across diverse care settings.
• In addition, the emergence of healthcare-specific LLM ecosystems and integration with electronic health record (EHR) platforms is strengthening the segment's long-term growth prospects. Enhanced interoperability, cloud-based deployment models, and improvements in model reliability and compliance are enabling broader adoption of LLM-powered applications across hospitals, physician practices, payers, and research institutions. As organizations continue to invest in generative AI, the LLM segment is expected to remain the largest contributor to the healthcare LLM and foundation model market.
• The vision foundation models segment accounted for USD 506.4 million in 2025. The segmental growth is driven by the increasing adoption of AI-based medical imaging solutions across radiology, pathology, and diagnostic workflows. Vision foundation models are widely utilized for image interpretation, disease detection, and workflow prioritization, helping healthcare providers improve diagnostic accuracy, reduce reading times, and enhance clinical decision-making.
• The multimodal foundation models segment is projected to expand at a CAGR of 28.5% from 2026 to 2035. The segmental growth is driven by the growing demand for AI systems capable of integrating and analyzing multiple healthcare data types, including clinical text, medical images, laboratory reports, and genomic information. These models are increasingly used in precision medicine, clinical decision support, and personalized treatment planning, enabling more comprehensive patient assessments and improved care outcomes.
• The biological and genomic foundation models segment accounted for USD 153.6 million in 2025. The segmental growth is driven by increasing adoption of AI in drug discovery, genomics research, biomarker identification, and molecular analysis. Pharmaceutical and biotechnology companies are leveraging these models to accelerate target discovery, optimize molecule development, improve clinical trial processes, and support the advancement of precision medicine initiatives.

Based on deployment mode, the healthcare LLM and foundation model market is classified into cloud-based and on-premise. The cloud-based segment dominated the market with the largest revenue share in 2025. The segment had a revenue share of 75.6% in 2025.

• Cloud deployment enables healthcare providers, payers, research institutions, and life sciences companies to access advanced LLMs and foundation models without the need for significant upfront investments in computing infrastructure. The increasing preference for cloud-hosted solutions also supports faster model deployment, real-time updates, seamless integration with healthcare systems, and improved accessibility across distributed care networks.
• Additionally, major technology providers and healthcare AI vendors are increasingly offering cloud-native platforms for clinical documentation, patient engagement, medical imaging, and drug discovery applications. Solutions such as Tempus Platform, Anthropic Claude for Healthcare, and OpenAI's healthcare offerings leverage cloud environments to deliver scalable AI capabilities while supporting secure data management, interoperability, and regulatory compliance.
• The growing adoption of Software-as-a-Service (SaaS) healthcare AI solutions continues to reinforce the dominance of the cloud-based segment in the healthcare LLM & foundation model market.
• The on-premise segment accounted for USD 585.6 million in 2025 and is expected to grow steadily during the forecast period. Growth is driven by increasing demand from hospitals, pharmaceutical and biotechnology companies, and research institutions for greater control over sensitive healthcare data, regulatory compliance, and data security. On-premise deployment is particularly preferred for large-scale clinical, imaging, genomic, and drug discovery applications where organizations require enhanced data governance.

Based on application, the healthcare LLM and foundation model market is classified into clinical documentation, medical imaging, drug discovery & development, patient engagement, and other applications. The clinical documentation segment dominated the market with the largest revenue share in 2025, owing to the widespread adoption of AI-powered ambient scribing, clinical note generation, medical coding, and workflow automation solutions across healthcare providers. The segment had a revenue share of 36.2% in 2025.

• The increasing administrative burden on healthcare professionals is a major factor driving the adoption of Healthcare LLMs in the clinical documentation segment. Growing documentation requirements, rising patient volumes, and physician burnout have accelerated demand for AI-powered ambient scribing, clinical note generation, and documentation automation solutions that enhance productivity while reducing time spent on administrative tasks.
• Healthcare providers are increasingly integrating LLM-powered documentation platforms into clinical workflows to improve operational efficiency and documentation quality. Solutions such as Suki Assistant, and Amazon HealthScribe enable real-time transcription, automated note creation, and clinical summarization, helping clinicians focus more on patient care and less on manual data entry.
• The widespread adoption of electronic health records (EHRs) and digital health systems continues to support segment growth. Advanced healthcare LLMs are being integrated directly with EHR platforms to streamline clinical workflows, improve documentation consistency, facilitate medical coding, and support regulatory compliance across hospitals, physician practices, and ambulatory care settings.
• The medical imaging segment accounted for USD 422.4 million in 2025. Growth is primarily driven by the increasing adoption of vision and multimodal foundation models in radiology, pathology, and diagnostic imaging workflows, enabling faster image interpretation, improved diagnostic accuracy, and enhanced clinical decision-making.
• The drug discovery & development segment is expected to expand at a CAGR of 28.4% from 2026 to 2035. This growth is attributed to the rising use of biological and genomic foundation models for target identification, molecule design, biomarker discovery, and clinical trial optimization, helping pharmaceutical and biotechnology companies accelerate R&D processes and reduce development timelines.
• The patient engagement segment accounted for USD 273.6 million in 2025. Demand is driven by the increasing deployment of AI-powered virtual assistants, conversational healthcare platforms, and care navigation tools that improve patient communication, appointment management, treatment adherence, and overall patient experience across healthcare systems.

Based on end use, the healthcare LLM and foundation model market is classified into hospitals, pharmaceutical and biotechnology companies, payers, research institutions, and other end users. The hospitals segment dominated the market with the largest revenue share in 2025, owing to the increasing adoption of healthcare LLMs and foundation models for clinical documentation, medical coding, clinical decision support, patient engagement, and workflow automation.

• Hospitals represent the primary end user segment in the healthcare LLM and foundation model market, as they generate large volumes of clinical, imaging, and patient data while managing complex care delivery workflows. Hospitals are increasingly adopting healthcare LLMs and foundation models for clinical documentation, medical coding, clinical decision support, patient engagement, and workflow automation to improve operational efficiency, reduce administrative burden, and enhance patient outcomes.
• Additionally, the growing integration of AI-powered solutions with electronic health record (EHR) systems and clinical information platforms is further supporting segment growth. Advanced solutions such as Nabla Ambient AI, Ambience AutoScribe + Inpatient CDI, and Hippocratic AI Platform are enabling healthcare organizations to streamline clinical documentation, enhance patient engagement, improve workflow efficiency, and support care delivery across diverse healthcare settings.
•  The strong focus on digital transformation, operational efficiency, and quality of care continues to reinforce hospitals as the leading end-user segment in the healthcare LLM and foundation model market
• The pharmaceutical and biotechnology companies segment accounted for significant revenue in 2025 and is anticipated to grow at a robust CAGR of 28.5% over the forecast period. Growth in this segment is driven by the increasing adoption of biological and genomic foundation models for drug discovery, target identification, biomarker discovery, molecule design, and clinical trial optimization.
• The payers segment accounted for notable revenue in 2025 and is expected to expand steadily during the forecast period. Growth is attributed to the rising use of healthcare LLMs and foundation models for claims processing, prior authorization, risk stratification, member engagement, and population health management.
• The research institutions segment accounted for a considerable share of the market in 2025 and is projected to grow at a strong CAGR from 2026 to 2035. This growth is driven by increasing utilization of healthcare foundation models for biomedical research, genomic analysis, disease modeling, scientific literature review, and translational research.

North America Healthcare LLM and Foundation Model Market

North America dominated the market with the highest market share of 42.5% in 2025.

• The U.S. healthcare LLM and foundation model industry was valued at USD 395.1 million and USD 505.5 million in 2022 and 2023, respectively. The market size reached USD 942 million in 2025, growing from USD 688.2 million in 2024, and is anticipated to grow at a CAGR of 27.5% from 2026 to 2035.
• North America, particularly the U.S., represents a significant market for Healthcare LLMs and Foundation Models, supported by the widespread adoption of electronic health records (EHRs), advanced healthcare IT infrastructure, and strong investments in artificial intelligence technologies.
• The region is witnessing increasing deployment of healthcare-specific AI solutions across clinical documentation, patient engagement, medical imaging, and clinical decision support workflows. Growing concerns regarding physician burnout, rising administrative burdens, and the need to improve healthcare efficiency continue to drive demand for healthcare LLMs and foundation models across hospitals and health systems.
• The region benefits from a mature digital healthcare ecosystem and the presence of leading technology providers and healthcare AI innovators. Advanced healthcare organizations are increasingly integrating solutions such as ambient documentation platforms, multimodal foundation models, and AI-powered diagnostic tools into routine clinical workflows. The availability of large healthcare datasets, established cloud infrastructure, and strong AI research capabilities further supports the development and adoption of healthcare-specific foundation models.
• Additionally, favorable funding environments, increasing healthcare AI investments, and supportive regulatory initiatives continue to strengthen market growth in North America.

Europe Healthcare LLM and Foundation Model Market

Europe market accounted for USD 646.7 million in 2025 and is anticipated to show lucrative growth over the forecast period.

• Europe represents a significant and steadily growing market for healthcare LLMs and foundation models, supported by the increasing digitalization of healthcare systems, growing adoption of electronic health records, and rising demand for AI-driven clinical and administrative solutions. Across countries such as Germany, France, and the UK, healthcare organizations are increasingly leveraging LLMs and foundation models for clinical documentation, patient engagement, medical imaging analysis, and healthcare workflow optimization to address workforce shortages and improve healthcare efficiency.
• Many European countries benefit from well-established healthcare infrastructures and strong government support for digital health transformation, enabling broader adoption of healthcare AI technologies. Hospitals, research institutions, and healthcare providers across the region are increasingly integrating AI-powered solutions into clinical and operational workflows, while pharmaceutical and biotechnology companies are utilizing foundation models to accelerate drug discovery, genomics research, and precision medicine initiatives.
• Additionally, the region's strong focus on responsible AI adoption, data governance, and regulatory compliance is supporting the development and deployment of healthcare-specific foundation models. Compliance with frameworks such as GDPR and emerging AI regulations is encouraging the adoption of secure and trustworthy AI solutions. As healthcare providers continue to invest in advanced analytics, clinical decision support, and multimodal AI platforms, Europe is expected to remain a key growth region for the healthcare LLM and foundation model industry.

Asia Pacific Healthcare LLM and Foundation Model Market

The Asia Pacific market is anticipated to grow at the highest CAGR of 28.5% during the analysis timeframe.

• Asia Pacific represents a rapidly growing market for healthcare LLMs and foundation models, driven by expanding digital health initiatives, increasing healthcare data generation, and rising investments in artificial intelligence across healthcare systems.
• Countries such as China, Japan, South Korea, India, and Australia are witnessing growing adoption of AI-powered clinical documentation, patient engagement, medical imaging, and healthcare workflow automation solutions as healthcare providers seek to improve efficiency and address workforce shortages.
• Healthcare systems across the region are increasingly emphasizing digital transformation and technology-enabled care delivery. Hospitals, research institutions, and healthcare organizations are adopting healthcare LLMs and foundation models to support clinical decision-making, streamline administrative workflows, enhance patient experiences, and improve diagnostic capabilities. In addition, the growing adoption of cloud-based healthcare AI platforms is enabling broader access to advanced AI technologies across both developed and emerging markets.
• Furthermore, the region's expanding pharmaceutical, biotechnology, and life sciences sectors are driving increased utilization of biological and genomic foundation models for drug discovery, genomics research, and precision medicine applications.

Latin America Healthcare LLM and Foundation Model Market

The Latin America market is experiencing robust growth over the analysis timeframe.

• Latin America represents an emerging market for healthcare LLMs and foundation models, supported by the ongoing digital transformation of healthcare systems and increasing investments in healthcare IT infrastructure across the region. Healthcare providers in countries such as Brazil, Mexico, and Argentina are increasingly adopting AI-powered solutions for clinical documentation, patient engagement, workflow automation, and diagnostic support to improve operational efficiency and address growing healthcare demands.
• Additionally, expanding access to digital health technologies and cloud-based healthcare platforms is strengthening the adoption of healthcare AI solutions throughout the region. Hospitals, physician practices, and healthcare organizations are leveraging large language models and foundation models to streamline administrative workflows, enhance patient communication, and improve clinical decision-making. Growing awareness of AI-driven healthcare applications is further supporting market penetration across both public and private healthcare systems.
• Furthermore, rising healthcare expenditure, increasing government efforts to modernize healthcare infrastructure, and growing investments in life sciences research are contributing to market growth in Latin America. Pharmaceutical and biotechnology companies are increasingly exploring foundation models for drug discovery, genomics research, and clinical development activities. As healthcare organizations continue to prioritize digital innovation and operational efficiency, the adoption of Healthcare LLMs and Foundation Models is expected to increase steadily across the region over the forecast period.

Middle East & Africa Healthcare LLM and Foundation Model Market

The Middle East & Africa (MEA) market is experiencing robust growth over the analysis timeframe.

• The Middle East & Africa (MEA) represents a developing market for healthcare LLMs and foundation models, driven by increasing investments in digital health transformation, rising adoption of healthcare IT solutions, and growing demand for AI-enabled healthcare services. The increasing burden of chronic diseases, expanding patient populations, and the need to improve healthcare accessibility are encouraging healthcare providers across the region to adopt AI-powered solutions for clinical documentation, patient engagement, and workflow optimization.
• Countries within the Gulf Cooperation Council (GCC), including Saudi Arabia and the United Arab Emirates, are making substantial investments in healthcare infrastructure, artificial intelligence, and digital health initiatives. These investments are supporting the deployment of healthcare LLMs and foundation models across hospitals, healthcare networks, and research organizations, enabling improved clinical decision support, operational efficiency, and patient care delivery.
• Furthermore, growing government-led digitization programs, increased cloud adoption, and expanding healthcare innovation ecosystems are contributing to market growth across the region. Pharmaceutical companies, research institutions, and healthcare providers are increasingly leveraging AI technologies for drug discovery, biomedical research, medical imaging, and precision medicine applications. As healthcare systems continue to modernize and prioritize technology-driven care, the adoption of healthcare LLMs and foundation models is expected to increase steadily across the Middle East & Africa over the forecast period.

Healthcare LLM and Foundation Model Market Share

The healthcare LLM & foundation model industry is characterized by moderate to high competition, driven by rapid advancements in generative AI, increasing adoption of healthcare-specific large language models and foundation models, and growing demand for AI-powered solutions across clinical documentation, patient engagement, medical imaging, drug discovery, and clinical decision support applications. Market participants are continuously investing in the development of domain-specific AI models, multimodal capabilities, and scalable deployment platforms to improve healthcare outcomes, workflow efficiency, and operational productivity.

Key players in the market include Microsoft, Google, NVIDIA, OpenAI, and Tempus AI, which collectively account for approximately ~48% of the total market share. These companies maintain strong competitive positions through extensive investments in artificial intelligence research, strategic partnerships with healthcare providers and life sciences organizations, robust cloud and computing infrastructure, and broad portfolios spanning healthcare LLMs, multimodal foundation models, medical imaging AI, and biological foundation models. Continuous innovation in clinical workflow automation, generative AI capabilities, and precision medicine applications further strengthens their market leadership.

In addition to the leading technology providers, several specialized healthcare AI companies such as Abridge, Hippocratic AI, Suki AI, Nabla, Aidoc, Paige AI, Viz.ai, BenevolentAI, Insilico Medicine, and Recursion Pharmaceuticals contribute significantly to market competition through focused solutions addressing specific clinical and life sciences use cases. These companies often compete through specialized healthcare expertise, workflow integration capabilities, and targeted AI applications. As healthcare organizations continue to accelerate digital transformation initiatives and foundation model adoption expands across clinical and research settings, competition in the market is expected to intensify, with vendors increasingly focusing on model accuracy, regulatory compliance, multimodal capabilities, and strategic collaborations to strengthen their market position.

Healthcare LLM and Foundation Model Market Companies

A few of the prominent players operating in the healthcare LLM and foundation model industry include:

• Abridge
• Aidoc
• Amazon Web Services
• Ambience Healthcare
• Anthropic
• BenevolentAI
• Elsevier
• Google
• Hippocratic AI
• Hyro
• Insilico Medicine
• Isomorphic Labs
• Microsoft
• Nabla
• NVIDIA
• OpenAI
• Orbita
• Paige AI
• Recursion Pharmaceuticals
• Suki AI
• Tempus AI
• Viz.ai
• Microsoft

Microsoft holds a leading position in the healthcare LLM and foundation model market through its strong portfolio of healthcare AI solutions, particularly DAX Copilot, which is widely used for ambient clinical documentation and workflow automation. The company’s competitive advantage stems from its deep integration with healthcare IT systems, extensive cloud infrastructure through Microsoft Azure, and strategic partnerships with healthcare providers.

• Google

Google maintains a strong competitive position in the market through its healthcare-focused AI offerings, including MedLM and MedGemma, as well as its advanced research capabilities through Google DeepMind. The company's strength lies in its expertise in large-scale foundation models, multimodal AI, and cloud-based healthcare solutions.

• Tempus AI

Tempus AI has established a strong presence in the healthcare LLM and foundation model market through its Tempus Platform, which integrates clinical, molecular, genomic, and real-world data to support precision medicine and healthcare decision-making. The company differentiates itself through its extensive healthcare data assets, advanced multimodal AI capabilities, and strong focus on oncology and personalized medicine.

Healthcare LLM and Foundation Model Industry News:

• In January 2026, OpenAI launched “OpenAI for Healthcare,” introducing ChatGPT for Healthcare and healthcare-focused API capabilities designed to support HIPAA-compliant clinical, research, and operational workflows. The launch enables healthcare organizations to deploy secure generative AI solutions for clinical documentation, decision support, and administrative automation. This development strengthens OpenAI’s position in the healthcare LLM & foundation model market and supports broader adoption of AI-powered healthcare applications across hospitals and health systems.

• In July 2025, Google expanded its MedGemma portfolio by launching new multimodal healthcare AI models, including MedGemma 27B Multimodal and MedSigLIP, designed for medical text, imaging, and clinical reasoning applications. The launch strengthens Google’s healthcare AI ecosystem by enabling developers to build advanced healthcare and life sciences applications across radiology, pathology, clinical documentation, and medical decision support. The development further reinforces Google's position in the market.

The healthcare LLM & foundation model market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Model Type

• Large language models (LLMs)

  • Clinical and documentation LLMs
  • Patient engagement LLMs
  • Biomedical research LLMs
• Vision foundation models
• Multimodal foundation models
• Biological and genomic foundation models

Market, By Deployment Mode

• Cloud-based

• On-premise

Market, By Application

• Clinical documentation

• Medical imaging
• Drug discovery and development
• Patient engagement
• Other applications

Market, By End Use

• Hospitals

• Pharmaceutical and biotechnology companies
• Payers
• Research institutions
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE